- Home
- O vs KVUE Comparison
O vs KVUE Comparison
Compare O & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- O
- KVUE
- Stock Information
- Founded
- O 1969
- KVUE 2022
- Country
- O United States
- KVUE United States
- Employees
- O N/A
- KVUE N/A
- Industry
- O Real Estate Investment Trusts
- KVUE Specialty Chemicals
- Sector
- O Real Estate
- KVUE Consumer Discretionary
- Exchange
- O Nasdaq
- KVUE Nasdaq
- Market Cap
- O 52.2B
- KVUE 43.6B
- IPO Year
- O N/A
- KVUE 2023
- Fundamental
- Price
- O $56.28
- KVUE $24.07
- Analyst Decision
- O Hold
- KVUE Buy
- Analyst Count
- O 15
- KVUE 12
- Target Price
- O $61.29
- KVUE $24.71
- AVG Volume (30 Days)
- O 5.0M
- KVUE 19.4M
- Earning Date
- O 05-05-2025
- KVUE 05-08-2025
- Dividend Yield
- O 5.64%
- KVUE 3.41%
- EPS Growth
- O 3.85
- KVUE N/A
- EPS
- O 1.10
- KVUE 0.54
- Revenue
- O $5,404,988,000.00
- KVUE $15,455,000,000.00
- Revenue This Year
- O $3.71
- KVUE $1.81
- Revenue Next Year
- O $4.93
- KVUE $4.00
- P/E Ratio
- O $51.30
- KVUE $44.73
- Revenue Growth
- O 22.95
- KVUE 0.07
- 52 Week Low
- O $50.71
- KVUE $17.67
- 52 Week High
- O $64.88
- KVUE $25.17
- Technical
- Relative Strength Index (RSI)
- O 46.19
- KVUE 59.03
- Support Level
- O $56.37
- KVUE $23.01
- Resistance Level
- O $57.55
- KVUE $24.20
- Average True Range (ATR)
- O 0.95
- KVUE 0.71
- MACD
- O -0.12
- KVUE 0.08
- Stochastic Oscillator
- O 2.80
- KVUE 64.92
About O Realty Income Corporation
Realty Income owns roughly 15,600 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, gaming, office, manufacturing, and distribution properties, which make up roughly 20% of revenue.
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.